KE / Domain	AOP entity (KE/KER)	Input (manipulation / sample)	Method / Assay (SOP notes)	Output / Measurement	Interpretation / Context fields to capture	Exemplar peer-reviewed manuscripts	Protocol / SOP notes (attach)	S&T considerations (ontology / mapping)
Airway Surface Liquid Height (decreased)	KE: ASL height, decreased (Event 1907); downstream of CFTR function ↓; included in AOP 424	Primary human airway epithelial cells at ALI; ASL labeled with fluorescent dextran or measured by X-ray microanalysis	Fluorescence microscopy for ASL height measurement. ASL labeled with fluorescent markers (e.g., dextran). Confocal or widefield microscopy with Z-stack acquisition. X-ray microanalysis for ion composition. Control for evaporation using humidified chamber or oil overlay.	ASL height (µm); Ion composition (Cl⁻, Na⁺, K⁺) by X-ray microanalysis; Mucus transport rate	Donor anatomical region; cell type; days at ALI; fluorescent label type and concentration; microscopy type; Z-resolution; temperature; humidity control; evaporation prevention method; imaging interval; replicate number	Roomans GM, Kozlova I, Nilsson H, Vanthanouvong V, Button B, and Tarran R. (2004). Measurements of airway surface liquid height and mucus transport by fluorescence microscopy, and of ion composition by X-ray microanalysis. J Cyst Fibros. 3 Suppl 2:135-9.	Include fluorescent labeling protocol, microscopy settings, Z-step size, evaporation control methods, X-ray microanalysis parameters if used, image analysis workflow	Biolink: Attribute (ASL height); OBI: fluorescence microscopy assay; Mapping: KE 1907; Metadata: units (µm), environmental control, ion composition linkage
Airway Surface Liquid Height (decreased) — Automated confocal	KE: ASL height, decreased (Event 1907); downstream of KER: CFTR function ↓ → ASL height ↓; included in AOP 424	Primary HAEC at ALI; ASL labeled with fluorescent dextran (e.g., Texas Red-dextran)	Live confocal XZ imaging with automated analysis. Acquire Z-stacks at defined intervals; automated segmentation algorithm for ASL height quantification. Perfluorocarbon overlay (e.g., FC-77) to prevent evaporation. Maintain 37°C and controlled humidity. Software-based automated detection of ASL surface boundaries.	ASL height (µm) over time; optional periciliary layer estimate with dual fluorescent labels; automated batch processing of multiple samples	Donor anatomical region (nose, large airway, small airway, alveolus); donor ID and passage number; donor genotype/phenotype; differentiation medium formulation; substrate type; days at ALI; fluorescent label type and concentration; imaging interval; objective NA and magnification; Z-step size; temperature/humidity; perfusate osmolality; gas conditions; perfluorocarbon type; analysis algorithm version; replicate number	Choi HC, Kim CS, and Tarran R. (2015). Automated acquisition and analysis of airway surface liquid height by confocal microscopy. Am J Physiol Lung Cell Mol Physiol. 309(2):L109-18.	Include confocal imaging settings (laser power, detector gain), Z-step size, automated analysis script or macro, perfluorocarbon overlay application, evaporation control validation, quality control for boundary detection accuracy	Biolink: Attribute (ASL height); OBI: confocal microscopy assay; Mapping: KE 1907; Metadata: units (µm), timebase, environmental context, automation for throughput; link to downstream KEs (CBF↓, MCC↓)
Airway Surface Liquid Height — μOCT	KE: ASL height, decreased (Event 1907); supports downstream KEs (CBF↓, MCC↓)	Primary HAEC at ALI or ex vivo tissue; μOCT system (~1–2 µm axial resolution)	Micro-Optical Coherence Tomography (μOCT). Non-contact, cross-sectional imaging of ASL depth, periciliary layer (PCL). Simultaneous measurement of ASL height, ciliary beat frequency, and mucociliary transport within the same field. Depth calibration with micron-scale phantom verified pre/post imaging.	ASL depth (µm); PCL depth (µm); CBF (Hz); MCT (mm/min); tissue microstructure	Donor anatomical region (nose, large airway, small airway, alveolus); donor ID and passage number; differentiation medium formulation; substrate type; days at ALI; system axial/lateral resolution; frame rate; calibration phantom; temperature; mucus state; illumination safety; analysis algorithm version	Liu L, Chu KK, Houser GH, Diephuis BJ, Li Y, Wilsterman EJ, et al. (2013). Method for quantitative study of airway functional microanatomy using micro-optical coherence tomography. PLoS One. 8(1):e54473.	Provide μOCT instrument configuration, calibration routine with phantom specifications, ROI selection rules, imaging parameters (frame rate, resolution, depth), analysis algorithm for layer segmentation, quality control metrics; include representative cross-sectional images for QC	Biolink: MeasurementProcess; OBI: optical coherence tomography assay; Mapping: KE 1907; Metadata: resolution, temperature, mucus state, non-contact advantage, multi-parameter simultaneous acquisition, analysis algorithm version
Airway Surface Liquid Height — intranasal μOCT	KE: ASL height, decreased (Event 1907); in vivo clinical application; supports mucociliary clearance assessment	Ex vivo human nasal tissue; in vivo intranasal imaging in human subjects; μOCT probe for clinical use	Intranasal micro-Optical Coherence Tomography (μOCT). Minimally invasive imaging of airway surface liquid in vivo. High-resolution cross-sectional imaging simultaneously measuring ASL depth, periciliary layer depth, ciliary beat frequency, and mucociliary transport. Non-contact optical imaging suitable for clinical use.	ASL depth (µm); Periciliary layer (PCL) depth (µm); Ciliary beat frequency (Hz); Mucociliary transport rate (mm/min)	Anatomical site (nasal region); subject characteristics (age, sex); disease state (cystic fibrosis vs healthy); environmental conditions (humidity, temperature); probe positioning protocol; imaging duration; frame rate; motion artifact correction; analysis software version; inter-subject variability; safety monitoring	Leung HM, Birket SE, Hyun C, Ford TN, Cui D, Solomon GM, et al. (2019). Intranasal micro-optical coherence tomography imaging for cystic fibrosis studies. Sci Transl Med. 11(504).	Include probe specifications and handling, patient preparation and positioning, imaging protocol, motion correction algorithms, ASL/PCL boundary detection methods, CBF extraction from motion signals, quality assessment criteria, safety considerations for in vivo use, regulatory compliance	Biolink: MeasurementProcess; OBI: optical coherence tomography assay; Mapping: KE 1907 and related KEs; Clinical translation; in vivo imaging capability; multi-parameter functional assessment; application to CF studies
Airway Surface Liquid regulation via CFTR modulation	KER: CFTR function ↑ → ASL height ↑ (rescue); part of AOP 424 network	Primary human CF airway epithelial cells (F508del-CFTR) cultured at ALI; treatment with VX-770 (CFTR potentiator)	Functional assessment of CFTR-mediated ion transport (Ussing chamber) with correlation to ASL height changes. Demonstrates relationship between CFTR function rescue and ASL volume restoration. Electrophysiology combined with morphological assessment.	CFTR-mediated current (µA/cm²); ASL height changes in response to modulator treatment; correlation between CFTR function and ASL volume	CF genotype (F508del homozygous); donor characteristics; culture conditions; days at ALI; modulator compound and concentration; treatment duration; electrophysiology parameters; ASL measurement method; baseline vs treated comparison	Van Goor F, Hadida S, Grootenhuis PD, Burton B, Cao D, Neuberger T, et al. (2009). Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci U S A. 106(44):18825-30.	Include CFTR modulator preparation and dosing, Ussing chamber protocol, ASL measurement timing relative to treatment, correlation analysis methods, controls (vehicle, wild-type cells)	Biolink: MeasurementProcess; OBI: transepithelial electrical measurement; Mapping: KER CFTR↑ → ASL↑; CHEBI: VX-770 (ivacaftor); CF therapeutic context; functional rescue demonstration
